About Niramai
Niramai is a Healthcare company based in Bengaluru (India) founded in 2016 by Geetha Manjunath. Early breast cancer is detected using AI-based non-invasive thermal imaging. Niramai has raised $8.63 million across 9 funding rounds from investors including HCG, Kotak Mahindra Bank and Murata Manufacturing. The company has 51 employees. Niramai was last valued at $24.09 million in October 2023. Its chief executive, as recorded, is Geetha Manjunath. Its Indian entity Niramai Health Analytix Private Limited reported revenue of ₹10.10 Cr. Niramai offers products and services including Thermalytix, Niramai SMILE 100, and Mythri. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
Niramai was established in 2016 in Bengaluru, India, within the health technology sector. An artificial intelligence-driven medical device is provided for non-invasive breast cancer screening. Thermal imaging technology is employed to assess chest temperature variations, achieving detection accuracy comparable to conventional approaches without radiation exposure. Operations include hospital and clinic-based screenings, at-home options, and community camp services across various settings.
- Headquarters Bengaluru, India
- Employees 51
- Founders Geetha Manjunath
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website niramai.com
- Social LinkedIn X Facebook Instagram
- Legal Name Niramai Health Analytix Private Limited
- Date of Incorporation 14 Jul, 2016
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹10.10 Cr
FY 2025 · +3% YoY
- Net Loss-₹7.87 Cr
FY 2025 · -78% margin
- EBITDA-₹7.32 Cr
FY 2025 · -72% margin
- Total Equity Funding$8.63M (USD)
in 9 rounds
- Latest Funding Round$625.32K (USD), Series A
Oct 2023
- InvestorsHCG
& 21 more
- Employee Count51
Associated legal entities of Niramai
Niramai operates through Niramai Health Analytix Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Niramai Health Analytix Private Limited CIN U72200KA2016PTC095020 | Active | 14 Jul 2016 | Bangalore, Karnataka | ₹10.1 Cr | 51 | 4 | View details |
Products & Services of Niramai
Niramai offers a comprehensive portfolio of products and services, including Thermalytix, Niramai SMILE 100, and Mythri.
AI-powered thermal imaging for early breast cancer detection.
FDA-cleared adjunct test for breast health analysis.
Low-cost tool for rapid breast health risk assessment.
Funding Insights of Niramai
Niramai has successfully raised a total of $8.63M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $625.32 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.63M
- Total Rounds 9
- Last Round Series A — $625,316
- First Round $1M
(Mar 2017)
- Investors Count 22
All 9 funding rounds of Niramai with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $625,316 | Series A | $24.09M | pi Ventures | |
| Jun 2021 | Grant | – | – | ||
| Oct 2020 | $6,812 | Grant | – | – | |
| Jun 2020 | Grant | – | – | ||
| Jul 2019 | Series A | – | T-Hub | – | |
| Feb 2019 | Grant | – | – | ||
| Nov 2018 | $7M | Series A | $22.29M | pi Ventures | |
| Aug 2017 | Grant | – | – | ||
| Mar 2017 | $1M | Seed | $••••• | pi Ventures, Ankur Capital |
| Date | Valuation | Stage |
|---|---|---|
| Oct 2023 | $24.09M | •••••••• |
| Nov 2018 | $22.29M | •••••••• |
| Mar 2017 | $••••• | •••••••• |
Full valuation and stage history of Niramai
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $24.09M (Oct 2023). 22 investors in total: 18 institutional and 4 angel.
Investors in Niramai
Niramai has secured backing from 22 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include HCG, Kotak Mahindra Bank and Murata Manufacturing.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm investing in early-stage startups in technology sectors. | 2014 | axilor.com | Bengaluru, India | |
Deep-tech venture capital investments in early-stage companies. | 2016 | piventures.in | Bengaluru, India | |
Indian fund focused on fintech, health, and climate initiatives. | rainmatter.com | Bengaluru, India | ||
Government agency focused on small and medium-sized businesses | 1948 | bii.co.uk | London, United Kingdom | |
Seed capital grants are provided to incubate and accelerate innovations. | 2020 | actgrants.in | Bengaluru, India | |
Innovation hub connecting startups, corporates, and partners in technology and ecosystem development. | 2015 | t-hub.co | Hyderabad, India | |
Promotion of innovation and digital services in Maharashtra. | 2017 | msins.in | Mumbai, India | |
Early-stage venture capital fund | beenext.com | Singapore, Singapore | ||
Early-stage investments in digital, climate, and deep science technologies. | 2011 | ankurcapital.com | Mumbai, India | |
Dream Incubator is engaged in strategic consulting and business incubation. | 2000 | dreamincubator.co.jp | Chiyoda City, Japan |
Investor details for Niramai
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Niramai Health Analytix Private Limited (Niramai)
Niramai Health Analytix Private Limited is the primary company behind Niramai. The board of Niramai Health Analytix Private Limited currently have 4 directors; the longest-serving is Geetha Manjunath, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Geetha Manjunath DIN 07565422 | Managing Director | 14 Jul 2016 | 10 yrs 3 mo | Niramai Health Analytix Private Limited |
| Manish Singhal DIN 00392528 | Nominee Director | 24 Jan 2019 | 7 yrs 9 mo | Niramai Health Analytix Private Limited |
| Munehiko Eto DIN 07172148 | Nominee Director | 15 Mar 2019 | 7 yrs 7 mo | Niramai Health Analytix Private Limited |
| Himanshu Jayantkumar Madhu DIN 09553175 | Director | 26 Apr 2022 | 4 yrs 6 mo | Niramai Health Analytix Private Limited |
People of Niramai
20 people are tracked at Niramai (8 in leadership, 12 in team); the tracked headcount is 51.
| Name | Role | Group |
|---|---|---|
| Co-Founder, CEO & CTO | Leadership | |
Siva Teja Kakileti | Principal Research Scientist & Director | Leadership |
Shireen Chopra | Head, HR | Leadership |
Vicky Nanda | COO | Leadership |
Shankar Boorla | Head of Finance | Leadership |
| Head of Products & Director | Leadership | |
Jyotsana Mal | Regional Head, International | Leadership |
Somdev Upadhyay | Head of Corporate Partnership | Leadership |
Kanchana Gopinath | Senior Manager Special Projects | Team |
Umar Farooq | Manager, Operations | Team |
Sneha Valluru | Senior Associate, QARA | Team |
Ronak Dedhiya | Research Engineer | Team |
Raghav Shrivastava | Research Engineer | Team |
Surajit Mukherjee | CBO | Team |
Sharath Kumar Dandu | Business Development Manager | Team |
Vijay Thakkar | Senior Business Development Manager | Team |
Sai Priya Rudraraju | Test Engineer | Team |
Avinash Donthula | Senior QARA Specialist | Team |
Indu Srinivasachar | Senior QA Manager | Team |
Kamal Valecha | Senior Business Development Manager | Team |
Complete people profiles for Niramai
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Niramai
Figures of Niramai Health Analytix Private Limited, the primary company behind Niramai, for FY 2025. Revenue was ₹10.10 Cr (+3% year on year). Net loss was -₹7.87 Cr (-78% margin). EBITDA was -₹7.32 Cr (-72% margin). Revenue has grown at a compounded annual rate of +21% over three years and +28% over five years.
- ₹10.10 CrRevenue · FY 2025 · +3% YoY
- -₹7.87 CrNet loss · -78% margin
- -₹7.32 CrEBITDA · -72% margin
- ₹11.9 LakhPaid-up capital
- 51Employees (provident fund records)
- +21%Revenue CAGR, 3 years
- +28%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Niramai Health Analytix Private Limited are on its company page.
Detailed financial statements for Niramai
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Niramai
4 dated milestones of Niramai across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Niramai is founded.
- Funding First funding round of $1.0M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $625K.
Web traffic of Niramai
The website of Niramai (niramai.com) receives about 9.9K visits a month.
- Monthly visits9.9K
▲ 36.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Niramai
Complete news archive for Niramai
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Niramai
Niramai was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Niramai is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Geetha Manjunath is the CEO of Niramai, as recorded in our data. They have also founded this company.
Niramai is a funded company, having raised a total of $8.63M across 9 funding rounds to date. The company's 1st funding round was a Seed of $1M, raised on Mar 2017.
Niramai has 51 employees.
The primary company behind Niramai, Niramai Health Analytix Private Limited, reported revenue of ₹10.10 Cr for FY 2025, up 3% year on year.
Niramai was established in 2016 in Bengaluru, India, within the health technology sector. An artificial intelligence-driven medical device is provided for non-invasive breast cancer screening. Thermal imaging technology is employed to assess chest temperature variations, achieving detection accuracy comparable to conventional approaches without radiation exposure. Operations include hospital and clinic-based screenings, at-home options, and community camp services across various settings.
Niramai offers Thermalytix, Niramai SMILE 100, and Mythri.
Niramai has 22 investors. Key investors include HCG, Kotak Mahindra Bank, Murata Manufacturing, T-Hub, and Ankur Capital.
The valuation of Niramai is $24.09M as of Oct 2023.
Niramai operates through Niramai Health Analytix Private Limited.
The legal entities of Niramai currently have 4 directors, including Geetha Manjunath, Manish Singhal, Munehiko Eto and others.